The following details were available for trading and market data about the stock of DexCom as of writing:
Trading Details of DexCom (DXCM)
Current Share Price:
$134.56
Previous Year's Closing Price:
$124.09
Percentage Price Change (YTD):
8.44%
Market Cap:
$52.49 billion
52-week Price Range:
$74.75 - $142
Dividend Per Share:
$0
EPS (TTM):
1.31
Price-Earnings (Trailing):
102.72
Price-Earnings (Forward):
60.34
Company Profile and Business Description for DexCom
Dexcom, Inc. (Dexcom), incorporated on May 13, 1999, is a medical device company. The Company is focused on the design, development and commercialization of continuous glucose monitoring systems for ambulatory use by people with diabetes and for use by healthcare providers for the treatment of pe...to see full details, pleaseLogin / Register to view.
ETFs Holding DexCom Stock
As of March 2020, the following exchange-traded funds (ETF) hold the DexCom stocks in their respective portfolios. Below is a random list of only 10 ETFs in no particular order that have DexCom stock holding. There are a total of 79 ETFs in Fknol.com records which are holding DexCom stock in their portfolio. See Full List.
The iShares MSCI ACWI ETF tracks a market-cap-weighted index of large- and midcap global stocks, covering 85% of the developed and emerging markets capitalization. ...Full Details ...Candlestick Patterns.
The AI Powered Equity ETF is an actively managed fund of US stocks selected by a proprietary, quantitative model that incorporates artificial intelligence (AI). ...Full Details
AVUS is an actively managed diverse portfolio of U.S. large-, mid-, and small-cap stocks aiming to find those with lower price relative to valuations. ...Full Details
The innovator IBD Breakout Opportunities ETF tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors. The fund may hold 50% T-bills based on technical market signals. ...Full Details
The iShares MSCI ACWI Low Carbon Target ETF tracks an index of stocks from global firms selected for a bias toward lower carbon emissions, but with tight constraints to the broad, marketlike ACWI index. ...Full Details
The Invesco Russell 1000 Equal Weight Index Portfolio tracks an index of the 1000 largest US stocks. Each sector receives equal weight, and each stock within a sector receives equal weight. ...Full Details
See Full List of ETFs holding DexCom stock in their respective portfolios.
U.S. Stock Screener:
Peer / Competitor Companies of Medical Dental Instruments Sector
Along with DexCom, Inc., the following other peer (competitor) companies also exist within the same Medical Dental Instruments - Healthcare sector whose company profile and dividend history is as follows:
▶ ABIOMED (ABMD): ABIOMED, Inc., incorporated on June 4, 1987, is a provider of temporary percutaneous mechanical circulatory support devices. The Company offers care to heart failure patients. The Company operates in the ....See Detailed Company Profile, Dividend History
▶ Accuray (ARAY): Accuray Incorporated, incorporated on February 22, 2001, is a radiation oncology company. The Company develops, manufactures, sells and supports treatment solutions. It develops, manufactures and markets medical devices used in ....See Detailed Company Profile, Dividend History
▶ Alphatec (ATEC): Alphatec Holdings, Inc., incorporated on March 4, 2005, is a medical technology company. The Company through its subsidiary, Alphatec Spine, Inc. and its subsidiaries (Alphatec Spine), designs, develops, manufactures and ....See Detailed Company Profile, Dividend History
▶ AngioDynamics (ANGO): AngioDynamics, Inc., incorporated on July 30, 1992, designs, manufactures and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment ....See Detailed Company Profile, Dividend History
▶ Anika Therapeutics (ANIK): Anika Therapeutics, Inc., incorporated on February 28, 1992, is an orthopedic medicines company. The Company is engaged in developing, manufacturing and commercializing products based on its hyaluronic acid (HA) technology. ....See Detailed Company Profile, Dividend History
▶ Antares Pharma (ATRS): Antares Pharma, Inc. (Antares), incorporated on April 29, 2005, is a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies. The Company develops, manufactures ....See Detailed Company Profile, Dividend History
▶ Asensus Surgical (ASXC): TransEnterix, Inc., incorporated in August 19, 1988, is a medical device company. The Company is focused on the development and commercialization of ALF-X Surgical Robotic System (the ALF-X System), a ....See
▶ Atossa Genetics (ATOS): Atossa Genetics Inc., incorporated on April 30, 2009, is a clinical-stage pharmaceutical company focused on the development of therapeutics and delivery methods for the treatment of breast cancer and other ....See Detailed Company Profile, Dividend History
▶ AtriCure (ATRC): AtriCure, Inc., incorporated on October 31, 2000, is an atrial fibrillation (Afib) solutions company. The Company develops, manufactures, and sells devices designed primarily for the surgical ablation of cardiac tissue ....See Detailed Company Profile, Dividend History
▶ Atrion (ATRI): Atrion Corporation (Atrion), incorporated on December 30, 1996, is engaged in developing and manufacturing products, primarily for medical applications. The Companys medical products range from fluid delivery devices to ophthalmic ....See Detailed Company Profile, Dividend History
▶ Avinger (AVGR): Avinger, Inc., incorporated on March 8, 2007, is a commercial-stage medical device company. The Company designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients ....See Detailed Company Profile, Dividend History
▶ Baxter International (BAX): Baxter International Inc., incorporated on October 19, 1931, through its subsidiaries, provides a portfolio of essential renal and hospital products, including acute and chronic dialysis; sterile intravenous (IV) solutions; infusion ....See Detailed Company Profile, Dividend History
▶ Becton Dickinson and (BDX): Becton, Dickinson and Company (BD), incorporated in November 1906, is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory ....See Detailed Company Profile, Dividend History
▶ Biolase (BIOL): BIOLASE, Inc. (BIOLASE), incorporated on February 10, 1987, is a medical device company that develops, manufactures, markets and sells laser systems in dentistry and medicine. The Company markets, sells, and ....See Detailed Company Profile, Dividend History
▶ Biomerica (BMRA): Biomerica, Inc., incorporated on September 22, 1971, is a biomedical company, which develops, manufactures and markets medical diagnostic products for the early detection and monitoring of chronic diseases and medical ....See Detailed Company Profile, Dividend History
▶ Biostage (BSTG): Biostage, Inc., formerly Harvard Apparatus Regenerative Technology, Inc., incorporated on May 3, 2012, is a biotechnology company. The Company is engaged in developing bioengineered organ implants based on its Cellframe ....See Detailed Company Profile, Dividend History
▶ Boston Scientific (BSX): Boston Scientific Corporation, incorporated on June 22, 1979, is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers ....See Detailed Company Profile, Dividend History and Recent Candlestick Patterns.
▶ Cantel Medical (CMD): Cantel Medical Corp., incorporated on August 16, 1963, is a provider of infection prevention products and services in the healthcare market. The Companys operating segments include Endoscopy; Water Purification and ....See Detailed Company Profile, Dividend History
▶ Cardiovascular (CSII): Cardiovascular Systems, Inc., incorporated on December 6, 2000, is a medical technology company. The Company is engaged in treating patients suffering from peripheral and coronary artery diseases, including those with ....See Detailed Company Profile, Dividend History
▶ Cerus (CERS): Cerus Corporation, incorporated on July 31, 1996, is a biomedical products company. The Company is engaged in developing and commercializing the INTERCEPT Blood System for blood safety. The Company operates ....See Detailed Company Profile, Dividend History